Egzistencinė terapija - Company finances
|
EUR
|
2023
From: 2023-06-12
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|
|
Financial data
|
|||
| Sales revenue | 18,986 | 44,770 | 43,745 |
| Profit before tax | 6,241 | -10,340 | 4,309 |
| Net profit | 6,241 | -10,340 | 4,309 |
| Equity | 6,341 | -3,999 | -762 |
| Liabilities | 0 | 7,110 | 5,022 |
| Non-current assets | 0 | 0 | 0 |
| Current assets | 6,341 | 3,111 | 4,260 |
| Total assets | 6,341 | 3,111 | 4,260 |
|
Taxes paid
|
|||
| STI taxes | 185 | 785 | 232 |
|
Financial indicators
|
|||
| Revenue change y/y | - | +135.8% | -2.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 98.4% | -332.4% | 101.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 98.4% | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 32.9% | -23.1% | 9.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 32.9% | -23.1% | 9.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Egzistencinė terapija - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-07-02 | 2024-07-31 | 129.00 |
| 2024-06-03 | 2024-07-01 | 64.50 |
| 2023-09-01 | 2023-09-30 | 117.26 |
| 2023-08-01 | 2023-08-31 | 58.63 |
Egzistencinė terapija - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Egzistencinė terapija is: 2 €
| From | To | Overdue, € |
|---|---|---|
| 2026-02-21 | 2026-09-02 | 2.34 |
| 2025-02-20 | 2026-02-03 | 2.34 |
| 2025-02-19 | 2025-02-19 | 0.04 |
| 2025-02-02 | 2025-02-10 | 2.3 |
| 2024-12-19 | 2025-02-01 | 2.04 |
| 2024-12-07 | 2024-12-18 | 1.3 |
| 2024-11-18 | 2024-12-06 | 2.04 |
| 2024-10-09 | 2024-11-17 | 1.3 |
| 2024-10-01 | 2024-10-08 | 2.04 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Egzistencine terapija, MB (company code 306337109) is a Lithuanian small partnership engaged in general medical practice activities. In 2025, the company generated revenue of €43.7K and net profit of €4.3K, with a profit margin of 9.9%. Revenue was slightly lower than in 2024, when turnover reached €44.8K, but the business returned to profit after a net loss of €10.3K in that year. In 2023, during a 202-day reporting period, revenue was €19.0K and net profit was €6.2K, indicating a strong increase in scale over the two-year span. Over the latest two-year period, revenue increased by 130.4%, while year-on-year revenue declined by 2.3% in 2025. The balance sheet remained small: total assets were €4.3K, equity was negative at €762, and liabilities were €5.0K. Return measures and leverage ratios are affected by the negative equity base, so they should be interpreted cautiously.